Bubonic plague claims 32 lives in Madagascar (Update)

by Lovasoa Rabary

Bubonic plague, which wiped out a third of Europe's population in the Middle Ages, has reared its ugly head in the African island state of Madagascar where 32 people have died in a fresh outbreak of the so-called Black Death disease, according to health authorities.

Some 84 suspected cases of bubonic plague—60 of them suspected of being pneumonic or pulmonary plague, a more virulent strain of the disease—have been reported in five of the island's 112 districts in the past month.

Pneumonic plague is caused by the same bacteria that occur in bubonic plague but, while bubonic plague is usually transmitted by bites from rat-borne fleas and can be treated with antibiotics, pneumonic plague can be inhaled and transmitted between humans without involvement of animals or fleas and, if untreated, has a very high fatality rate, experts say. It can kill within 24 hours.

Last year, Madagascar reported 60 deaths from bubonic plague. Poor hygiene and declining living standards as a result of a protracted political crisis since a coup in 2009 are cited as the primary causes of the spread of the disease.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Boy dies of bubonic plague in Kyrgyzstan

Aug 26, 2013

A teenage boy has died of bubonic plague in Kyrgyzstan, the country's health officials confirmed Monday, adding that an epidemic was not likely.

US approves new treatment for ancient plague

Apr 27, 2012

Hardly anyone succumbs to the bubonic plague these days, but US health authorities on Friday approved a new treatment for it and other forms of the potentially deadly bacterial infection.

Recommended for you

Sierra Leone, Liberia brace for new Ebola cases

11 hours ago

Two of the West African nations hardest hit by Ebola were bracing for new caseloads on Monday after trying to outflank the outbreak with a nationwide checkup and a large new clinic.

Reversing the effects of pulmonary fibrosis

12 hours ago

Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.

User comments